- Globally rare BRCA2 variants with founder haplotypes in the South African population: Implications for point-of-care testing based on a single-institution BRCA1/2 next-generation sequencing study.
- Oosthuizen J, Kotze MJ, Van Der Merwe NV, Myburgh EJ, Bester P, Van Der Merwe NC.
- Front Oncol. 2020 Dec 23;10:619469. doi: 10.3389/fonc.2020.619469.
Category: Provider Education
- Only One-in-Three Breast Cancer Patients Offered Potentially Life Saving Genomic Test.
- [No author given]
- Clinical OMICs. 2020 Dec 9.
- Conference news
- Free Full Text
- Knowledge and practice regarding prostate cancer germline testing among urologists: Gaps to address for optimal implementation.
- Loeb S, Byrne N, Walter D, Makarov DV, Wise DR, Becker D, Giri VN.
- Cancer Treat Res Commun. 2020 Sep 28;25:100212. doi: 10.1016/j.ctarc.2020.100212. Epub ahead of print.
- PMID: 33091732
- PubMed abstract
- Genetic counseling in prostate cancer: How to implement it in daily clinical practice?
- Borque-Fernando A, Espílez R, Miramar D, Corbatón D, Rodríguez A, Castro E, Mateo J, Rello L, Méndez A, Gil Sanz MJ.
- Actas Urol Esp. 2020 Oct 12:S0210-4806(20)30194-7. English, Spanish. doi: 10.1016/j.acuro.2020.08.009. Epub ahead of print.
- PMID: 33059945
- PubMed abstract
- Source abstract
- Review, [Article in Spanish]
- Testing a Best Practices Risk Result Format to Communicate Genetic Risks.
- Davis K, Roter DL, Schmidlen T, Scheinfeldt LB, Klein WMP.
- Patient Educ Couns. 2020 Oct 19:S0738-3991(20)305589. doi: 10.1016/j.pec.2020.10.021. Epub ahead of print.
- Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?
- Fadda M, Chappuis PO, Katapodi MC, Pagani O, Monnerat C, Membrez V, Unger S, Caiata Zufferey M.
- PLoS One. 2020 Oct 8;15(10):e0240054. doi: 10.1371/journal.pone.0240054.
- PMID: 33031463
- PubMed abstract
- "I think that a brief conversation from their provider can go a very long way": Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer.
- Mallen AR, Conley CC, Fuzzell L, Ketcher D, Augusto BM, McIntyre M, Barton LV, Townsend MK, Fridley BL, Tworoger SS, Wenham RM, Vadaparampil ST.
- Support Care Cancer. 2020 Sep 25. doi: 10.1007/s00520-020-05779-1. Epub ahead of print.
- PMID: 32975643
- PubMed abstract
- Source abstract
- Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer.
- Scheinberg T, Goodwin A, Ip E, Linton A, Mak B, Smith DP, Stockler MR, Strach MC, Tran B, Young AL, Zhang AY, Mahon KL, Horvath LG.
- JCO Oncol Pract. 2020 Sep 24:OP2000399. doi: 10.1200/OP.20.00399. Epub ahead of print.
- PMID: 32970524
- PubMed abstract
- Source abstract
LitAlert ~~ GeneLit.com
- The Impact of the Number of Tests Presented and a Provider Recommendation on Decisions about Genetic Testing for Cancer Risk.
- Schwartz MLB, Klein WMP, Erby LAH, Smith CH, Roter DL.
- Patient Educ Couns. 2020 Sep 18:S0738-3991(20)305188. doi: 10.1016/j.pec.2020.09.020. Epub ahead of print.
- Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.
- Green RF, Kumerow MT, Rodriguez JL, Addie S, Beachy SH, Senier L.
- Public Health Genomics. 2020 Sep 17:1-12. doi: 10.1159/000510336. Epub ahead of print.
- PMID: 32942283
- PubMed abstract
- Source abstract
Original research:
Proposed outcomes measures for state public health genomic programs.
- PMID: 29300382
- PubMed abstract
- Free Full Text
- Examining information-seeking behavior in genetic testing for cancer predisposition: a qualitative interview study.
- Zimmermann BM, Fanderl J, Koné I, Rabaglio M, Bürkic N, Shaw D, Elgera B.
- Patient Educ Couns. 2020 Sep 17:S0738-3991(20)305176. doi: 10.1016/j.pec.2020.09.019. Epub ahead of print.